MOTS-c

MS40

Lyophilized peptide for use under a licensed healthcare provider. Choose single ampule/vial or box of 10. Sourced via Ares Technology Limited (Hong Kong) / Healthtide Biotech manufacturing list dated 7 October 2026. Specification: 40 mg × 10 vials.

• Prescription / clinician-supervised pathway
• Same LIRAVEXIN cart and checkout as pen packages
• Not medical advice — individual suitability is determined by your clinician

Clinical reference (clinician-supervised)

What it is used for

Investigational metabolic and aging research. Not an approved metabolic drug.

Typical dose ranges

No established approved human dose. Early human research exposures are protocol-specific—clinician/trial only.

Frequency

Protocol-specific.

Route

Research SC/other—protocol-defined.

Typical clinical / literature ranges under clinician supervision — not a prescription and not a DIY dosing guide. Individual dosing is determined solely by the treating clinician.

Rx / HCP callout: Intended for adult use under supervision of a licensed healthcare provider. This page does not provide medical advice. Liravexin USD prices reflect the wholesale comparison sheet (source × 3).

Cat. No.

MS40

Pack size

Specification

40 mg × 10 vials

Quantity

$480 USD

Liravexin USD for this pack (wholesale comparison · source × 3). Item is added to your shared cart for checkout coordination with your clinician pathway.

Or continue to checkout →